Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis of Novel Allylthio Heterocyclo(or aryl)alkylaminopyridazines and Their Anticancer Activity against SK-Hep-1 Cells

  • Published : 2009.01.20
Download PDF
⟨ Previous Next ⟩

Abstract

To develop new anticancer agents, 3-allylthio-6-aminopyridazine derivatives were synthesized from maleic anhydrides or phthalic anhydrides by formation of a pyridazine nucleus, dichlorination, allylthiolation and amination. The pyridazine nuclei were obtained by condensing a hydrazine monohydrate with maleic anhydride. An allylthio group as a pharmacologically active group was introduced into one side of a pyridazine ring. Arylalkylamines with benzene or pyridine moieties or heterocycloalkylamines with heterocycle moieties such as morpholine, piperidine, or pyrrolidine were also introduced into the para-position of allylthio pyridazine. These new compounds showed antiproliferative activities against SK-Hep-1 human liver cancer cells in MTT assays. These compounds are thus promising candidates for chemotherapy of hepatocellular carcinomas. Two compounds, 20c and 22a, showed higher potencies for inhibiting growth of hepatocellular carcinoma cells than did K6 ($ID_50$=1.08 mM). This suggests the potential anticancer activity of these two compounds.

Keywords

References

  1. Lee, J. I.; Park, H.; Yun, Y. S.; Kwon, S. K. J. Kor. Chem. Soc. 2001, 45, 386
  2. Kwon, S. K.; Kim, M. K. Yakhak Hoeji 2002, 46, 89
  3. Kwon, S. K. Yakhak Hoeji 2002, 46, 155
  4. Kwon, S. K.; Moon, A. R. Arch. Pharm. Res. 2005, 4, 391
  5. Jung, M. Y.; Kwon, S. K.; Moon, A. Eur. J. Cancer 2001, 37, 2104 https://doi.org/10.1016/S0959-8049(01)00242-8
  6. Tisler, M.; Stanovnik, B. Advances in Heterocyclic Chemistry; Katritzky & Boulton, Eds.; 1984; Vol. 3, pp 1-56
  7. Song, J. H.; Kim, S. G.; No, Z. S.; Hyun, Y. L.; Jeon, D. J.; Kim, I. Bull. Korean Chem. Soc. 2008, 29, 1467 https://doi.org/10.5012/bkcs.2008.29.8.1467
  8. Contreras, J. M.; Parrot, I.; Sippl, W.; Rival, Y. M.; Wermuth, C. G. J. Med. Chem. 2001, 44, 2707 https://doi.org/10.1021/jm001088u
  9. Parrot, I.; Wermuth, C. G.; Hibert, M. Tetrahedron Lett. 1999, 40, 7975 https://doi.org/10.1016/S0040-4039(99)01533-6
  10. Wermuth, C. G.; Bourguignon, J.; Schlewer, G.; Gies, J.; Schoenfelder, A.; Melikian, A.; Bouchet, M. J. Med. Chem. 1987, 30, 239 https://doi.org/10.1021/jm00385a003
  11. Shin, H. S.; Kwon, S. K. Arch. Pharm. Res. 2003, 5, 351
  12. Wermuth, C. G.; Schlewer, G.; Bourguignon, J. J.; Maghiros, G.; Bouchet, M. J.; Moire, C.; Kan, J. P.; Worms, P.; Biziere, K. J. Med. Chem. 1989, 32, 528 https://doi.org/10.1021/jm00123a004
  13. Kleemann, A.; Engel, J. Pharmaceutical Substances, 4th ed.; 2001; pp 1340-1342
  14. Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon, J. J.; Wermuth, C. G. J. Med. Chem. 1999, 42, 730 https://doi.org/10.1021/jm981101z
  15. Park, E. H.; Park, M. S. Yakhak Hoeji 2005, 49(1), 56
  16. Park, E. H.; Park, M. S. J. Kor. Chem. Soc. 2007, 51(3), 244 https://doi.org/10.5012/jkcs.2007.51.3.244
  17. Kwon, S. K.; Lee, M. S. Yakhak Hoeji 2005, 49(6), 505
  18. Parrot, I.; Rival, Y.; Wermuth, C. G. Synthesis 1999, 7, 1163
  19. Lu, Z.; Twieg, R. J. Tetrahedron 2005, 61, 903 https://doi.org/10.1016/j.tet.2004.11.017
  20. Eldrup, A. B.; Dahl, O.; Nielsen, P. J. Am. Chem. Soc. 1997, 119, 1116 https://doi.org/10.1021/ja962058c
  21. Beletskaya, I.; Bessmertnykh, G.; Guilard, R. Tetrahedron Lett. 1999, 40, 6393 https://doi.org/10.1016/S0040-4039(99)01246-0
  22. Tewari, A.; Hein, M.; Zapt, A.; Beller, M. Tetrahedron 2005, 61, 9705 https://doi.org/10.1016/j.tet.2005.06.067
  23. Yokoyama, R.; Ito, S.; Okujima, T.; Kubo, T.; Yasunami, M.; Tajiri, A.; Morita, N. Tetrahedron 2003, 59, 8191 https://doi.org/10.1016/j.tet.2003.08.048

Cited by

  1. Incorporation of pyridazine rings in the structure of functionalized π-conjugated materials vol.1, pp.3, 2011, https://doi.org/10.1039/c1ra00207d
  2. Novel Alkylaminopyridazine Derivatives: Synthesis and Their Anti-proliferative Effects against MCF-7 Cells vol.34, pp.11, 2013, https://doi.org/10.5012/bkcs.2013.34.11.3317
  3. Design, Synthesis, and Biological Evaluation of Selenium-incorporated Aminopyridazines as Anticancer Agents vol.36, pp.6, 2015, https://doi.org/10.1002/bkcs.10319
  4. Synthesis and Antiproliferative Activities of Chloropyridazine Derivatives Retain Alkylsulfonyl Moiety vol.37, pp.11, 2016, https://doi.org/10.1002/bkcs.10967
  5. ChemInform Abstract: Synthesis of Novel Allylthio Heterocyclo(or aryl)alkylaminopyridazines and Their Anticancer Activity Against SK-Hep-1 Cells. vol.40, pp.28, 2009, https://doi.org/10.1002/chin.200928141
  6. Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines vol.33, pp.2, 2010, https://doi.org/10.1007/s12272-010-0201-x
  7. Synthesis and Antitumor Activity of New 3-Allylseleno-6-alkoxypyridazines against Breast Cancer MCF-7 Cells vol.35, pp.5, 2009, https://doi.org/10.5012/bkcs.2014.35.5.1533
  8. RKO 대장암세포에서 3-헵틸아미노-6-알릴티오피리다진과 3-디펜틸아미노-6-알릴티오피리다진의 항암기전 vol.60, pp.3, 2009, https://doi.org/10.17480/psk.2016.60.3.101
  9. Base Promoted Three-Component Annulation of 4-Diazoisochroman-3-imines with Dimethylsulfonium Ylides: Synthesis of Highly Functionalized Isochromeno[4,3-c]pyridazines vol.86, pp.1, 2021, https://doi.org/10.1021/acs.joc.0c02204